Publication from BIOV Science AdvisorI came across a paper from Kartik Chandron PhD ay Albert Einstein in NYC---he's a Scientific Advisor for BIOV--- that was just published in the peer reviewed journal Cell. Its about a bispecific antibody-based therapeutic against Crimean-Congo hemorrhagic fever virus----ok, not an area of commercial interest (yet) for BIOV, but proves he's a good catch for them! No doubt he will be of help with their haptenized recombinant virtal antigen vaccine program. Good advisors, including the recent C. Duntion MD, can really help a company.
Here's the link for anyone who is interested:
https://www.sciencedirect.com/science/article/pii/S0092867421005845?dgcid=author